U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Secretory diarrhea

MedGen UID:
75635
Concept ID:
C0267557
Disease or Syndrome
Synonym: Diarrhea, secretory
SNOMED CT: Secretory diarrhea (15699003)
 
HPO: HP:0005208
Monarch Initiative: MONDO:0000249

Definition

Watery voluminous diarrhea resulting from an imbalance between ion and water secretion and absorption. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSecretory diarrhea

Conditions with this feature

Congenital secretory diarrhea, chloride type
MedGen UID:
78631
Concept ID:
C0267662
Disease or Syndrome
Congenital secretory chloride diarrhea is an autosomal recessive form of severe chronic diarrhea characterized by excretion of large amounts of watery stool containing high levels of chloride, resulting in dehydration, hypokalemia, and metabolic alkalosis. The electrolyte disorder resembles the renal disorder Bartter syndrome (see 607364), except that chloride diarrhea is not associated with calcium level abnormalities (summary by Choi et al., 2009). Genetic Heterogeneity of Diarrhea Other forms of diarrhea include DIAR2 (251850), caused by mutation in the MYO5B gene (606540) on 18q21; DIAR3 (270420), caused by mutation in the SPINT2 gene (605124) on 19q13; DIAR4 (610370), caused by mutation in the NEUROG3 gene (604882) on 10q21; DIAR5 (613217), caused by mutation in the EPCAM gene (185535) on 2p21; DIAR6 (614616), caused by mutation in the GUCY2C gene (601330) on 12p12; DIAR7 (615863) caused by mutation in the DGAT1 gene (604900) on 8q24; DIAR8 (616868), caused by mutation in the SLC9A3 gene (182307) on 5p15; DIAR9 (618168), caused by mutation in the WNT2B gene (601968) on 1p13; DIAR10 (618183), caused by mutation in the PLVAP gene (607647) on 19p13; DIAR11 (618662), caused by deletion of the intestine critical region (ICR) on chromosome 16p13, resulting in loss of expression of the flanking gene PERCC1 (618656); DIAR12 (619445), caused by mutation in the STX3 gene (600876) on 11q12; and DIAR13 (620357), caused by mutation in the ACSL5 gene (605677) on chromosome 10q25.
Hypertrophic osteoarthropathy, primary, autosomal dominant
MedGen UID:
382429
Concept ID:
C2674695
Disease or Syndrome
Autosomal dominant primary hypertrophic osteoarthropathy (PHOAD) is characterized by 3 major features: digital clubbing, periostosis, and pachydermia. Patients may also experience joint swelling and pain, and some have reported gastrointestinal symptoms, including watery diarrhea. Males are more commonly affected, and more severely affected, than females (Lee et al., 2016; Xu et al., 2021). Touraine et al. (1935) recognized pachydermoperiostosis (PDP) as a familial disorder with 3 presentations or forms: a complete form with periostosis and pachydermia, an incomplete form without pachydermia, and a forme fruste with pachydermia and minimal skeletal changes. Genetic Heterogeneity Autosomal recessive forms of PHO have been reported (see 259100), including PHOAR2E (614441), which is also caused by mutation in the SLCO2A1 gene. Patients with autosomal recessive PHO do not experience gastrointestinal symptoms.
Hypertrophic osteoarthropathy, primary, autosomal recessive, 2
MedGen UID:
482430
Concept ID:
C3280800
Disease or Syndrome
PHOAR2-enteropathy syndrome (PHOAR2E) is characterized by primary hypertrophic osteoarthropathy (PHO) and/or chronic nonspecific ulcers (CNSU) of the small intestine. The cardinal features of PHO are digital clubbing, pachydermia, and periostosis; other manifestations include swelling and pain of the large joints, hyperhidrosis, seborrhea, and acne. CNSU often presents with chronic unexplained anemia and abdominal pain, and patients may exhibit edema due to hypoalbuminemia. Radiologic imaging or endoscopy shows multiple small ulcers, predominantly in the ileum, although the stomach, duodenum, and jejunum are often involved. PHO is more frequent and more severe in male patients, who often also report watery diarrhea, whereas CNSU is more often diagnosed in female patients, who may also show features of PHO such as digital clubbing or arthralgias and swelling of the joints. The same mutations in the SLCO2A1 gene have been reported in patients presenting with either diagnosis, and presumed sex-related modifiers of the manifestations of disease or other genotype/phenotype correlates have yet to be elucidated (Li et al., 2017; Umeno et al., 2018; Hong et al., 2022; Kimball et al., 2024). For a discussion of genetic heterogeneity of PHO, see PHOAR1 (259100).
Periodic fever-infantile enterocolitis-autoinflammatory syndrome
MedGen UID:
863504
Concept ID:
C4015067
Disease or Syndrome
Autoinflammation with infantile enterocolitis is an autosomal dominant disorder characterized by onset of recurrent flares of autoinflammation in early infancy. Affected individuals tend to have poor overall growth and gastrointestinal symptoms in infancy associated with laboratory evidence of activated inflammation. This initial presentation is followed by recurrent febrile episodes with splenomegaly and sometimes hematologic disturbances, arthralgias, or myalgias. The disorder results from overactivation of an arm of the immune response system (Romberg et al., 2014; Canna et al., 2014).
Inflammatory skin and bowel disease, neonatal, 2
MedGen UID:
863567
Concept ID:
C4015130
Disease or Syndrome
Neonatal nephrocutaneous inflammatory syndrome (NNCIS) is an autosomal recessive disorder characterized by intrauterine growth retardation and premature birth, fragile infection-prone skin, and nephromegaly with tubular dysfunction. Some patients have chronic diarrhea, and necrotizing enterocolitis with intestinal perforation has been observed. Other features include facial dysmorphisms and cardiac anomalies. Most patients require ventilatory and circulatory support at birth, exhibit failure to thrive, experience recurrent infections with sepsis as a common complication, and die within 6 months (Mazurova et al., 2020; Labbouz et al., 2023). Reviews Takeichi and Akiyama (2021) reviewed published reports of patients with mutation in the EGFR gene, whose features included intrauterine growth restriction; thin, translucent, and fragile skin (14 of 15 cases); skin desquamation (10 of 17 cases); ichthyosis (9 of 17 cases); recurrent skin infections and sepsis (9 of 12 cases); nephromegaly (10 of 16 cases); and congenital heart defects (7 of 17 cases). Other observed features included erythroderma, tubulopathy, necrotizing enterocolitis/intestinal perforation, cryptorchidism, hyperimmunoglobulin E, and dentinogenesis imperfecta. Almost all children died within 2.5 years after birth. The authors suggested that EGFR-associated systemic inflammatory diseases should be considered a part of the clinical spectrum of 'autoinflammatory keratinization diseases' (AiKDs).
Diarrhea 10, protein-losing enteropathy type
MedGen UID:
1648311
Concept ID:
C4748579
Disease or Syndrome
Diarrhea-10 (DIAR10) is a protein-losing enteropathy characterized by intractable secretory diarrhea and massive protein loss due to leaky fenestrated capillaries. Features include early-onset anasarca, severe hypoalbuminemia, hypogammaglobulinemia, and hypertriglyceridemia, as well as electrolyte abnormalities. Some patients exhibit facial dysmorphism and cardiac and renal anomalies. Intrafamilial variability has been observed, and the disease can be severe, with death occurring in infancy in some patients (Broekaert et al., 2018; Kurolap et al., 2018). For a discussion of genetic heterogeneity of diarrhea, see DIAR1 (214700).
Congenital secretory sodium diarrhea 3
MedGen UID:
1778108
Concept ID:
C5441927
Disease or Syndrome
Any secretory diarrhea in which the cause of the disease is a mutation in the SPINT2 gene.
Congenital secretory sodium diarrhea 8
MedGen UID:
1783137
Concept ID:
C5441928
Disease or Syndrome
Any secretory diarrhea in which the cause of the disease is a mutation in the SLC9A3 gene.
Osteootohepatoenteric syndrome
MedGen UID:
1785846
Concept ID:
C5543557
Disease or Syndrome
Osteootohepatoenteric syndrome (OOHE) is characterized by a variable combination of bone fragility, hearing loss, cholestasis, and congenital diarrhea. Some patients also display mild developmental delay and intellectual disability (Esteve et al., 2018).
Diarrhea 12, with microvillus atrophy
MedGen UID:
1794152
Concept ID:
C5561942
Disease or Syndrome
Microvillus inclusion disease (DIAR12) is a congenital enteropathy characterized by neonatal-onset intractable secretory diarrhea, resulting in severe dehydration and metabolic acidosis. Patients may tolerate limited enteral feeding, but are dependent on total parenteral nutrition (TPN) and require eventual small bowel and/or liver transplantation. Pathologic hallmarks include variable loss of brush-border microvilli, microvillus inclusions, and accumulation of subapical vesicles in villus enterocytes (summary by Wiegerinck et al., 2014). Another form of microvillus inclusion disease, MVID1 (DIAR2; 251850), is caused by mutation in the MYO5B gene (606540). For a discussion of genetic heterogeneity of diarrhea, see DIAR1 (214700). Mutations in the STX3 gene that affect only isoform A (STX3A) cause DIAR12, whereas mutations in STX3 affecting both STX3A and isoform B (STX3B), which predominates in retinal tissue, cause a syndrome involving severe early-onset retinal dystrophy and MVID (RDMVID; 619446).
Immunodeficiency 87 and autoimmunity
MedGen UID:
1794280
Concept ID:
C5562070
Disease or Syndrome
Immunodeficiency-87 and autoimmunity (IMD87) is an autosomal recessive immunologic disorder with wide phenotypic variation and severity. Affected individuals usually present in infancy or early childhood with increased susceptibility to infections, often Epstein-Barr virus (EBV), as well as with lymphadenopathy or autoimmune manifestations, predominantly hemolytic anemia. Laboratory studies may show low or normal lymphocyte numbers, often with skewed T-cell subset ratios. The disorder results primarily from defects in T-cell function, which causes both immunodeficiency and overall immune dysregulation (summary by Serwas et al., 2019 and Fournier et al., 2021).
Diarrhea 13
MedGen UID:
1841113
Concept ID:
C5830477
Disease or Syndrome
Diarrhea-13 (DIAR13) is characterized by neonatal onset of recurrent vomiting and chronic watery diarrhea, resulting in severe failure to thrive. Supportive treatment includes medium-chain triglyceride (MCT)-based formula and/or total parenteral nutrition (TPN), and symptoms resolve after the age of 18 months (Al-Thihli et al., 2021). For a discussion of genetic heterogeneity of congenital diarrhea, see DIAR1 (214700).

Professional guidelines

PubMed

Burgers K, Lindberg B, Bevis ZJ
Am Fam Physician 2020 Apr 15;101(8):472-480. PMID: 32293842
Liu EH, Solorzano CC, Katznelson L, Vinik AI, Wong R, Randolph G
Endocr Pract 2015 May;21(5):534-545. doi: 10.4158/EP14464.DSC. PMID: 25962092Free PMC Article
Cottreau J, Tucker A, Crutchley R, Garey KW
Expert Rev Gastroenterol Hepatol 2012 Feb;6(1):17-23. doi: 10.1586/egh.11.87. PMID: 22149578

Recent clinical studies

Etiology

Biswal S
Recent Pat Antiinfect Drug Discov 2014;9(2):136-43. doi: 10.2174/1574891x10666150408153356. PMID: 25851117
Corinaldesi R, Stanghellini V, Barbara G, Tomassetti P, De Giorgio R
Intern Emerg Med 2012 Oct;7 Suppl 3:S255-62. doi: 10.1007/s11739-012-0827-4. PMID: 23073866
Terrin G, Tomaiuolo R, Passariello A, Elce A, Amato F, Di Costanzo M, Castaldo G, Canani RB
Int J Mol Sci 2012;13(4):4168-4185. Epub 2012 Mar 29 doi: 10.3390/ijms13044168. PMID: 22605972Free PMC Article
Senderowicz AM
Oncogene 2003 Sep 29;22(42):6609-20. doi: 10.1038/sj.onc.1206954. PMID: 14528286
Schiller LR
Curr Gastroenterol Rep 1999 Oct;1(5):389-97. doi: 10.1007/s11894-999-0020-8. PMID: 10980977

Diagnosis

Jonathan Medernach, Middleton JP
Clin Perinatol 2022 Jun;49(2):537-555. Epub 2022 Apr 21 doi: 10.1016/j.clp.2022.02.015. PMID: 35659102
Dawod E, Crawford CV
Clin Geriatr Med 2021 Feb;37(1):103-117. Epub 2020 Nov 2 doi: 10.1016/j.cger.2020.08.008. PMID: 33213765
Burgers K, Lindberg B, Bevis ZJ
Am Fam Physician 2020 Apr 15;101(8):472-480. PMID: 32293842
Belei OA, Heredea ER, Boeriu E, Marcovici TM, Cerbu S, Mărginean O, Iacob ER, Iacob D, Motoc AGM, Boia ES
Rom J Morphol Embryol 2017;58(2):371-376. PMID: 28730220
Krejs GJ
Am J Med 1987 May 29;82(5B):37-48. doi: 10.1016/0002-9343(87)90425-6. PMID: 3035922

Therapy

Liu F, Kaplan AL, Levring J, Einsiedel J, Tiedt S, Distler K, Omattage NS, Kondratov IS, Moroz YS, Pietz HL, Irwin JJ, Gmeiner P, Shoichet BK, Chen J
Cell 2024 Jul 11;187(14):3712-3725.e34. Epub 2024 May 28 doi: 10.1016/j.cell.2024.04.046. PMID: 38810646Free PMC Article
Anand S, Mandal S, Patil P, Tomar SK
Eur J Clin Microbiol Infect Dis 2016 Nov;35(11):1721-1739. Epub 2016 Jul 29 doi: 10.1007/s10096-016-2726-5. PMID: 27473379
Biswal S
Recent Pat Antiinfect Drug Discov 2014;9(2):136-43. doi: 10.2174/1574891x10666150408153356. PMID: 25851117
Palaniswamy C, Frishman WH, Aronow WS
Cardiol Rev 2012 Jul-Aug;20(4):167-76. doi: 10.1097/CRD.0b013e31824c866e. PMID: 22314145
Schiller LR
Curr Gastroenterol Rep 1999 Oct;1(5):389-97. doi: 10.1007/s11894-999-0020-8. PMID: 10980977

Prognosis

Estefanía-Fernández K, Andrés A, Alcolea A, Velayos-López M, Pastrían LG, Ramírez-Amorós C, Gonzalez R, Sarría M, Ramos E, López-Santamaria M, Hernández F
Pediatr Transplant 2022 Aug;26(5):e14270. Epub 2022 Mar 20 doi: 10.1111/petr.14270. PMID: 35307919
Biswal S
Recent Pat Antiinfect Drug Discov 2014;9(2):136-43. doi: 10.2174/1574891x10666150408153356. PMID: 25851117
Palaniswamy C, Frishman WH, Aronow WS
Cardiol Rev 2012 Jul-Aug;20(4):167-76. doi: 10.1097/CRD.0b013e31824c866e. PMID: 22314145
Mäkelä S, Kere J, Holmberg C, Höglund P
Hum Mutat 2002 Dec;20(6):425-38. doi: 10.1002/humu.10139. PMID: 12442266
Schiller LR
Curr Gastroenterol Rep 1999 Oct;1(5):389-97. doi: 10.1007/s11894-999-0020-8. PMID: 10980977

Clinical prediction guides

Bose A, Banerjee S, Visweswariah SS
IUBMB Life 2020 Jun;72(6):1145-1159. Epub 2020 Apr 15 doi: 10.1002/iub.2283. PMID: 32293781Free PMC Article
David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ
mBio 2015 May 19;6(3):e00381-15. doi: 10.1128/mBio.00381-15. PMID: 25991682Free PMC Article
Cottreau J, Tucker A, Crutchley R, Garey KW
Expert Rev Gastroenterol Hepatol 2012 Feb;6(1):17-23. doi: 10.1586/egh.11.87. PMID: 22149578
Orlowski J, Grinstein S
Pflugers Arch 2004 Feb;447(5):549-65. Epub 2003 Jul 4 doi: 10.1007/s00424-003-1110-3. PMID: 12845533
Krejs GJ
Am J Med 1987 May 29;82(5B):37-48. doi: 10.1016/0002-9343(87)90425-6. PMID: 3035922

Recent systematic reviews

Raicevic M, Saxena AK
World J Pediatr 2018 Aug;14(4):330-334. Epub 2018 Jul 10 doi: 10.1007/s12519-018-0170-6. PMID: 29992379
Bazerbachi F, Haffar S, Szarka LA, Wang Z, Prokop LJ, Murad MH, Camilleri M
Neurogastroenterol Motil 2017 Nov;29(11) Epub 2017 Jun 5 doi: 10.1111/nmo.13120. PMID: 28580600

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...